Solvency II: capital charge for PE could be lower than expected
The capital charge associated with private equity in the Solvency II directive could ultimately be lowered from the current 49% to 39%, unquote" understands.
More on Regulation
Unquote Private Equity Podcast: Jersey strikes the balance
Head of funds Elliot Refson discusses the blend of innovation and stability that the island offers to private equity
Guernsey Finance launches fast-track applications for managers
Scheme aims to allow fund managers with funds not registered in whitelisted jurisdictions to migrate
Guernsey Finance launches green PE principles
Four key principles to mitigate climate change at every investment stage and within GP boards
BVCA proposes £500m early-stage funding facility
Submission proposes a bridge funding facility in the form of a convertible loan of up to £5m per company
Latest News
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018
Eurazeo raises €2.8bn in 2020
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
ICG hires Bridge Valley's life sciences investment team
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline